0001213900-23-097671.txt : 20231221
0001213900-23-097671.hdr.sgml : 20231221
20231221160127
ACCESSION NUMBER: 0001213900-23-097671
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231219
FILED AS OF DATE: 20231221
DATE AS OF CHANGE: 20231221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bodenstedt Matthias
CENTRAL INDEX KEY: 0001920545
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39630
FILM NUMBER: 231505223
MAIL ADDRESS:
STREET 1: DORFSTRASSE 29
CITY: ZUG
STATE: V8
ZIP: 6300
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MoonLake Immunotherapeutics
CENTRAL INDEX KEY: 0001821586
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: DORFSTRASSE 29
CITY: ZUG
STATE: V8
ZIP: 6300
BUSINESS PHONE: 41 41 510 8022
MAIL ADDRESS:
STREET 1: DORFSTRASSE 29
CITY: ZUG
STATE: V8
ZIP: 6300
FORMER COMPANY:
FORMER CONFORMED NAME: Helix Acquisition Corp
DATE OF NAME CHANGE: 20200818
4
1
ownership.xml
X0508
4
2023-12-19
0
0001821586
MoonLake Immunotherapeutics
MLTX
0001920545
Bodenstedt Matthias
C/O MOONLAKE IMMUNOTHERAPEUTICS
DORFSTRASSE 29
ZUG
V8
6300
SWITZERLAND
0
1
0
0
Chief Financial Officer
1
Class A ordinary shares, par value $0.0001 per share
2023-12-19
4
S
0
94736
59.22
D
526167
D
Class A ordinary shares, par value $0.0001 per share
2023-12-20
4
S
0
5264
58.34
D
520903
D
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 19, 2023.
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $56.655 to $60.13. Upon request by the staff of the U.S. Securities and Exchange Commission (the "Commission"), the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $57.53 to $59.27. Upon request by the staff of the Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
/s/ Matthias Bodenstedt
2023-12-21